Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia.
Abstract
This study was conducted to examine the effects of contingent monetary reinforcement (CM) for smoking reduction, with and without transdermal nicotine, on cigarette smoking in individuals with schizophrenia. Fourteen outpatients participated in each of 3 conditions: (a) CM combined with 21 mg transdermal nicotine, (b) CM combined with placebo patch, and (c) noncontingent reinforcement combined with placebo patch. Each condition lasted 5 days. Carbon monoxide levels were measured 3 times daily, and nicotine withdrawal symptoms were measured once daily in each condition. Results indicated that CM reduced smoking but that 21 mg transdermal nicotine did not enhance that effect. These results offer further evidence supporting the efficacy of CM for reducing smoking among people with schizophrenia, but higher doses of nicotine replacement therapy, or another pharmacotherapy, may be needed to enhance that effect.
Cites (8)
- Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatmentFagerström, Karl-Olov · 1978 · Addictive Behaviors
- Signs and Symptoms of Tobacco WithdrawalHughes, John R. · 1986 · Archives of General Psychiatry
- Prevalence of smoking among psychiatric outpatients1986 · American Journal of Psychiatry
- The development and initial validation of a questionnaire on smoking urgesTIFFANY, STEPHEN T., DROBES, DAVID J. · 1991 · British Journal of Addiction
- Tobacco withdrawal in self-quittersHughes, John R. · 1992 · Journal of Consulting and Clinical Psychology
- Predicting Smoking Cessation: Who Will Quit With and Without the Nicotine PatchKenford, Susan L. · 1994 · JAMA
- Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disordersDiwan, Aparna, Castine, Michael, Pomerleau, Cynthia S., Meador-Woodruff, James H., Dalack, Gregory W. · 1998 · Schizophrenia Research
- Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotineBenowitz, Neal L., Zevin, Shoshana, Jacob, Peyton · 1998 · The Journal of Pharmacology and Experimental Therapeutics
Cited by (7)
- A meta-analysis of voucher-based reinforcement therapy for substance use disordersLussier, Jennifer Plebani, Heil, Sarah H., Mongeon, Joan A., Badger, Gary J., Higgins, Stephen T. · 2006 · Addiction
- Clinical Implications of Reinforcement as a Determinant of Substance Use DisordersHiggins, Stephen T., Heil, Sarah H., Lussier, Jennifer Plebani · 2004 · Annual Review of Psychology
- BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAPLingford-Hughes, AR, Welch, S, Peters, L, Nutt, DJ, With expert reviewers (in alphabetical order): Ball D, Buntwal N, Chick J, Crome I, Daly C, Dar K, Day E, Duka T, Finch E, Law F, Marshall EJ, Munafo M, Myles J, Porter S, Raistrick D, Reed LJ, Reid A, Sell L, Sinclair J, Tyrer P, West R, Williams T, Winstock A · 2012 · Journal of Psychopharmacology
- Interventions for smoking cessation and reduction in individuals with schizophreniaTsoi, Daniel T, Porwal, Mamta, Webster, Angela C · 2013 · Cochrane Database of Systematic Reviews
- Schizophrenia and the α7 Nicotinic Acetylcholine ReceptorMartin, Laura F., Freedman, Robert · 2007 · International Review of Neurobiology
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. https://app.cochat.ai/papers/10.1037//1064-1297.10.3.241
- The paper
- Tidey, J. W., O'Neill, S. C., & Higgins, S. T. (2002). Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037//1064-1297.10.3.241
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.